News | Cardiovascular Business | May 16, 2022

Boston Scientific Co-founder and Former CEO Passes Away

Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific from 1979 to 1999 and a corporate visionary in the minimally invasive surgery industry, passed away peacefully on May 14 just a few days before his 81st birthday. 

Pete Nicholas. Image courtesy of Boston Scientific


May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific from 1979 to 1999 and a corporate visionary in the minimally invasive surgery industry, passed away peacefully on May 14 just a few days before his 81st birthday. 

Boston Scientific Chairman and CEO Mike Mahoney said, “As a pioneer who helped shape the field of minimally invasive surgery, Pete Nicholas is remembered worldwide for his contribution to vastly improved patient outcomes and equally impressive increases in healthcare efficiency.” Mahoney added, “Within the Boston Scientific family, Pete was also a lifelong mentor, motivator and friend to hundreds of employees.”

According to a tribute posted on BostonScientific.com, he was an avid sailor, former lieutenant in the U.S. Navy, and beloved helmsman and career navigator to two generations of his Boston Scientific family of leaders and co-workers. Though he turned over his CEO duties in 1999, Nicholas retained an active role at Boston Scientific as chairman of the board until stepping down in 2016. A dealmaker and entrepreneurial risk-taker, Nicholas and co-founder John Abele built Boston Scientific from a startup with fewer than 50 employees and financed with a $500,000 loan and $300,000 in partners’ capital  into a global industry leader with 27,000 employees and $8.4 billion in revenue in 2016.

For more information: https://www.bostonscientific.com


Related Content

News | Heart Failure

February 22, 2024 — Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding ...

Home February 22, 2024
Home
News | Heart Failure

February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its ...

Home February 15, 2024
Home
News | Heart Failure

February 12, 2023 — A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully ...

Home February 12, 2024
Home
News | Heart Failure

January 30, 2024 — Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single ...

Home January 30, 2024
Home
News | Heart Failure

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home January 23, 2024
Home
News | Heart Failure

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

Home January 16, 2024
Home
News | Heart Failure

November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 30, 2023
Home
News | Heart Failure

November 30, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home November 30, 2023
Home
News | Heart Failure

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

Home November 16, 2023
Home
News | Heart Failure

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

Home November 16, 2023
Home
Subscribe Now